Grape King Bio Ltd reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 2,722.47 million compared to TWD 2,503.87 million a year ago. Net income was TWD 384.99 million compared to TWD 325.82 million a year ago. Basic earnings per share from continuing operations was TWD 2.6 compared to TWD 2.2 a year ago. Diluted earnings per share from continuing operations was TWD 2.59 compared to TWD 2.2 a year ago.
For the six months, sales was TWD 4,775.05 million compared to TWD 4,476.07 million a year ago. Net income was TWD 620.72 million compared to TWD 558.36 million a year ago. Basic earnings per share from continuing operations was TWD 4.19 compared to TWD 3.8 a year ago. Diluted earnings per share from continuing operations was TWD 4.17 compared to TWD 3.79 a year ago.